AstraZeneca Cancer Pipeline Seen As Draw For Pfizer
April 21, 2014 at 07:22 AM EDT
Pfizer could make another bid for AstraZeneca after its reported $101B takeover was rejected, since a deal could bolster Pfizer's cancer franchise.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.